SCL.NYSEStepan CO

DEF 14A: Stepan Company Announces 2024 Annual Meeting of Stockholders, Outlines Executive Compensation and Governance

Sentiment:

Proxy Statement


Stepan Company's proxy statement details the agenda for the 2024 Annual Meeting of Stockholders, including director elections, executive compensation approval, and auditor ratification.

Worse than expectedThe company reported a 73% decrease in net income in 2023 compared to 2022.The company reported a 67% decrease in adjusted net income in 2023 compared to 2022.The Surfactant segment delivered operating income of $72.4 million, a 56% decrease versus prior year.The Polymer segment delivered $60.8 million of operating income, a 27% decrease versus the prior year.Specialty Product operating income was $11.5 million, a 62% decrease versus prior year.

Summary

  • Stepan Company will hold its 2024 Annual Meeting of Stockholders on April 30, 2024, at its Northbrook, Illinois headquarters.
  • The meeting agenda includes the election of three directors, an advisory vote on executive compensation (Say-on-Pay), and the ratification of Deloitte & Touche LLP as the company's independent registered public accounting firm for 2024.
  • The record date for determining stockholders eligible to vote is March 4, 2024.
  • The proxy statement provides information on director nominees, executive compensation, corporate governance, and related matters.
  • In 2023, the company reported net income of $40.2 million, or $1.75 per diluted share, compared to $147.2 million, or $6.38 per diluted share, in 2022, a 73% decrease.
  • The company's adjusted net income was $50.7 million, or $2.21 per diluted share, versus $153.5 million, or $6.65 per diluted share, in 2022, a 67% decrease.
  • The Surfactant segment delivered operating income of $72.4 million, a 56% decrease versus prior year.
  • The Polymer segment delivered $60.8 million of operating income, a 27% decrease versus the prior year.
  • Specialty Product operating income was $11.5 million, a 62% decrease versus prior year.
  • For the full year, the Company paid $32.9 million of dividends.
  • The company has increased the dividend on its Common Stock for the 56th consecutive year.
  • The advisory Say-on-Pay vote was supported by 98% of votes cast at the company's 2023 Annual Meeting.
  • Due to the company's 2023 financial performance, the NEOs did not receive any annual incentive awards for 2023.
  • The performance shares that were granted to the NEOs in February 2023 under the company's long-term incentive plan were forfeited.
  • The committee determined that the 2023 NEO compensation was competitive, reasonable, and aligned with both company performance and stockholder interests.

Sentiment

Score: 4

Explanation: The document presents a mixed sentiment. While it highlights positive aspects like dividend increases and Say-on-Pay support, it also reveals significant declines in net income and operating income across various segments. The overall tone is cautiously optimistic but acknowledges the challenges faced by the company.

Positives

  • The company has increased the dividend on its Common Stock for the 56th consecutive year.
  • The advisory Say-on-Pay vote was supported by 98% of votes cast at the company's 2023 Annual Meeting.
  • The committee determined that the 2023 NEO compensation was competitive, reasonable, and aligned with both company performance and stockholder interests.

Negatives

  • The company reported a 73% decrease in net income in 2023 compared to 2022.
  • The company reported a 67% decrease in adjusted net income in 2023 compared to 2022.
  • The Surfactant segment delivered operating income of $72.4 million, a 56% decrease versus prior year.
  • The Polymer segment delivered $60.8 million of operating income, a 27% decrease versus the prior year.
  • Specialty Product operating income was $11.5 million, a 62% decrease versus prior year.
  • Due to the company's 2023 financial performance, the NEOs did not receive any annual incentive awards for 2023.
  • The performance shares that were granted to the NEOs in February 2023 under the company's long-term incentive plan were forfeited.

Risks

  • The company's financial performance in 2023 was significantly lower than in 2022, which could impact investor confidence.
  • Failure to achieve financial performance objectives could result in lower executive compensation and potentially impact employee morale.
  • Economic downturns or industry-specific challenges could further impact the company's financial results.
  • The company's reliance on specific business segments (Surfactants, Polymers, Specialty Products) exposes it to risks associated with those segments' performance.
  • The company's exposure to global markets exposes it to risks associated with international economic and political conditions.

Future Outlook

The company may furnish proxy materials to stockholders by providing access to these documents on the internet instead of mailing printed copies.

Industry Context

The document provides insights into Stepan Company's performance and governance practices within the chemical industry, allowing stakeholders to assess its competitiveness and alignment with industry standards.

Comparison to Industry Standards

  • The document references a peer group of companies in the chemical industry, including AdvanSix Inc., Ashland Inc., Avient Corporation, Cabot Corporation, The Chemours Company, H.B. Fuller Company, Innospec Inc., Koppers Holdings, Inc., NewMarket Corporation, Quaker Chemical Corporation, RPM International Inc., and Sensient Technologies Corporation.
  • Executive compensation is benchmarked against median compensation levels in the peer group.
  • The company's stock ownership policy is reviewed against peer group and general industry benchmarks.
  • The company's performance is compared to the Dow Jones U.S. Chemicals Index.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Executive Vice President, Supply ChainArthur W. MergnerRobert J. Haire, Jr.2023-05-01Retirement of Arthur W. Mergner
Interim Chief Human Resources OfficerNADavid G. Kabbes2023-04-03Interim role

Related Party Transactions

  • Mr. Richard Stepan, brother of F. Quinn Stepan, Jr., Chairman of the Board, is a current officer of the Company and receives a base salary, short-term and long-term incentive compensation as appropriate for his position and other regular and customary employee benefits generally available to all Company employees and is eligible for other limited perquisites available to employees at his level within the organization.
  • For 2023, Mr. Richard Stepan was paid a salary of $329,000, and a long-term incentive compensation award of RSUs, SARs and performance shares with a target value of $450,000.
  • Mr. Richard Stepan did not receive a short-term incentive compensation award for 2023.
  • The Audit Committee approved the Company's employment of Mr. Richard Stepan pursuant to the Related Party Transaction Policy and procedures described above.

Stakeholder Impact

  • Stockholders are impacted by the company's financial performance and executive compensation decisions.
  • Employees are impacted by the company's compensation policies and benefit programs.
  • The company's performance and governance practices can impact its relationships with customers, suppliers, and creditors.

Next Steps

  • Stockholders are encouraged to vote on the proposals outlined in the proxy statement.
  • The Board of Directors will review the voting results and take them into consideration when making future decisions.
  • The company will hold its 2024 Annual Meeting of Stockholders on April 30, 2024.

Key Dates

DateDescription
2006-06-30Company froze the Retirement Plan for Salaried Employees and ended the benefit accrual for all participants.
2023-08-18Gregory E. Lawton, a director since 2006, passed away.
2024-03-04Record date for determining stockholders eligible to vote at the Annual Meeting.
2024-03-26Proxy statement and proxy are first being distributed to stockholders.
2024-04-30Annual Meeting of Stockholders to be held at 9:00 a.m. (CDT).
2024-11-26Deadline for stockholders to submit proposals for inclusion in the 2025 Proxy Statement.
2024-12-31Earliest date for stockholders to submit notice of director nominations or other business for the 2025 Annual Meeting.
2025-01-30Latest date for stockholders to submit notice of director nominations or other business for the 2025 Annual Meeting.
2025-03-03Deadline for stockholders intending to solicit proxies in support of director nominees to provide notice to the Company.

Keywords

Annual Meeting, Proxy Statement, Executive Compensation, Board of Directors, Director Election, Say-on-Pay, Auditor Ratification, Corporate Governance, Financial Performance, Net Income, Adjusted Net Income, Stepan Company

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.